While there’s no argument that pharmaceuticals provide significant clinical benefits for patients, there remains little information for consumers as to how pharmaceutical manufacturers establish their prices. With prescription drug prices continuing to rise — estimates are 18 percent of medical spending is attributable to prescription drugs — a new issue brief from the New York Health Plan Association looks at current pharmacy cost trends and poses a number of policy initiatives aimed at addressing rising pharmaceutical prices and ensuring consumers have access to much needed therapies.